Salbiya, Loida .
HRN: 27-35-61 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CEFUROXIME 500MG (TAB)
06/21/2025
06/28/2025
PO
1 Tab
BID
SP NSVD W RMLE
Checking Initial Appropriateness
06/25/2025
CEFUROXIME 500MG (TAB)
06/25/2025
06/27/2025
PO
500mg
BID
NSVD AND RMLE
Checking Initial Appropriateness